Unmasking allosteric-binding sites: novel targets for GPCR drug discovery

dc.contributor.authorCasadó Anguera, Verònica
dc.contributor.authorCasadó, Vicent
dc.date.accessioned2026-01-19T18:07:59Z
dc.date.available2026-01-19T18:07:59Z
dc.date.issued2022-08-12
dc.date.updated2026-01-19T18:07:59Z
dc.description.abstractIntroduction: Unexpected non-apparent and hidden allosteric-binding sites are non-classical and non-apparent allosteric centers in 3-D X-ray protein structures until orthosteric or allosteric ligands bind to them. The orthosteric center of one protomer that modulates binding centers of the other protomers within an oligomer is also an unexpected allosteric site. Furthermore, another partner protein can also produce these effects, acting as an unexpected allosteric modulator. Areas covered: This review summarizes both classical and non-classical allosterism. The authors focus on G protein-coupled receptor (GPCR) oligomers as a paradigm of allosteric molecules. Moreover, they show several examples of unexpected allosteric sites such as hidden allosteric sites in a protomer that appear after the interaction with other molecules and the allosterism exerted between orthosteric sites within GPCR oligomer, emphasizing on the allosteric modulations that can occur between binding sites. Expert opinion: The study of these new non-classical allosteric sites will expand the diversity of allosteric control on the function of orthosteric sites within proteins, whether GPCRs or other receptors, enzymes, or transporters. Moreover, the design of new drugs targeting these hidden allosteric sites or already known orthosteric sites acting as allosteric sites in protein homo- or hetero-oligomers will increase the therapeutic potential of allosterism.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec723800
dc.identifier.issn1746-0441
dc.identifier.urihttps://hdl.handle.net/2445/225750
dc.language.isoeng
dc.publisherInforma Healthcare
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1080/17460441.2022.2085684
dc.relation.ispartofExpert Opinion on Drug Discovery, 2022, vol. 17, num.8, p. 897-923
dc.relation.urihttps://doi.org/10.1080/17460441.2022.2085684
dc.rights(c) Informa Healthcare, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Bioquímica i Biomedicina Molecular)
dc.subject.classificationCentres actius (Bioquímica)
dc.subject.classificationEnzims al·lostèrics
dc.subject.classificationProteïnes G
dc.subject.otherBinding sites (Biochemistry)
dc.subject.otherAllosteric enzymes
dc.subject.otherG Proteins
dc.titleUnmasking allosteric-binding sites: novel targets for GPCR drug discovery
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
250875.pdf
Mida:
1.3 MB
Format:
Adobe Portable Document Format